Otezla and Pregnancy, Breastfeeding, and More

When you are managing plaque psoriasis, psoriatic arthritis, or oral ulcers related to Behçet’s disease, medication decisions can already feel like a small board meeting inside your brain. Add pregnancy, breastfeeding, fertility questions, birth control, and side effects into the mix, and suddenly the meeting has snacks, charts, conflicting opinions, and one person asking, “Wait, can I take this if I’m trying to have a baby?”

Otezla, the brand name for apremilast, is an oral prescription medicine that works inside inflammatory pathways. It is not a steroid, not a biologic injection, and not a traditional immune-suppressing medication in the same way many older systemic treatments are. Still, “different” does not automatically mean “safe for every life stage.” Pregnancy and breastfeeding are special situations because the decision is not only about controlling symptoms; it is also about protecting fetal development, infant feeding, maternal health, and long-term treatment stability.

This guide explains what is currently known about Otezla and pregnancy, breastfeeding, fertility, birth control, and related safety issues. The key theme is simple: the available human data are limited, animal data raise some concerns, and decisions should be made with a healthcare professional who understands your diagnosis, symptom severity, pregnancy plans, and treatment history.

What Is Otezla?

Otezla contains apremilast, a medication classified as a phosphodiesterase 4, or PDE4, inhibitor. In plain English, it helps calm certain inflammatory signals involved in conditions such as plaque psoriasis and psoriatic arthritis. Instead of putting out every alarm in the immune system, it works more like turning down a few noisy knobs on the inflammation dashboard.

In the United States, Otezla is used for adults with active psoriatic arthritis, adults with plaque psoriasis who are candidates for phototherapy or systemic therapy, and adults with oral ulcers associated with Behçet’s disease. Current labeling also includes certain pediatric uses for patients 6 years and older who meet weight and diagnosis requirements. Otezla XR, an extended-release version, is also available for certain patients.

Because Otezla is taken by mouth, many people find it less intimidating than injections or infusions. But oral medication still travels through the body, which is why pregnancy and breastfeeding questions matter. A tiny tablet can have a surprisingly big résumé.

Is Otezla Safe During Pregnancy?

There is no simple “yes” or “no” answer that applies to everyone. Current prescribing information says that available human pregnancy data have not established a clear drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. However, those human data are extremely limited. That means the absence of a proven risk is not the same as proof of safety.

Animal studies are one reason clinicians are cautious. In animal reproduction studies, apremilast was associated with an increased risk of fetal loss at certain exposure levels. Animal studies do not always predict what will happen in humans, but they are taken seriously when human information is sparse.

For someone who becomes pregnant while taking Otezla, the first step is not panic and not a dramatic medication breakup scene. The practical step is to contact the prescribing clinician promptly. A dermatologist, rheumatologist, obstetrician, or maternal-fetal medicine specialist can help weigh the risk of continuing treatment against the risk of uncontrolled disease.

Why Untreated Disease Also Matters

Pregnancy safety discussions sometimes focus only on medication risk, but untreated inflammatory disease can also create problems. Severe psoriasis may cause pain, sleep disruption, skin cracking, infection risk, stress, and reduced quality of life. Psoriatic arthritis can affect mobility, daily function, and inflammation levels. Behçet’s disease can involve painful oral ulcers and other systemic symptoms.

In other words, the goal is not simply “avoid all medication.” The goal is to find the safest effective plan. Sometimes that means pausing a medicine before conception. Sometimes it means switching to an option with more pregnancy experience. Sometimes it means using topical therapy or phototherapy. The right plan depends on the person, the disease, and the timing.

Otezla and Pregnancy Planning

If you are planning a pregnancy, talk with your healthcare provider before trying to conceive. This gives your care team time to review your current treatment, disease control, past flares, other medications, and safer alternatives if needed. Pregnancy planning is much easier before the calendar suddenly says, “Surprise.”

Current labeling advises pregnancy planning and prevention for females of reproductive potential because of the potential risk to a fetus. This does not mean every person who has taken Otezla will have a pregnancy problem. It means the evidence is limited enough that careful planning is recommended.

Questions to Ask Before Trying to Conceive

Useful questions include: How active is my psoriasis, psoriatic arthritis, or Behçet’s disease right now? Are there treatment options with more pregnancy safety experience? Should I stop Otezla before trying to become pregnant? If so, when? What symptoms should I watch for if my condition flares? Who should coordinate my care during pregnancy?

These questions may sound basic, but they prevent a common problem: making medication decisions in a hurry. Pregnancy planning is like packing for a long trip. You do not want to discover at the airport that your passport, socks, and treatment plan are all missing.

What If You Took Otezla Before Knowing You Were Pregnant?

Many pregnancies are discovered after a medication has already been taken. If that happens with Otezla, contact your healthcare provider as soon as you can. Do not make medication changes without medical guidance. Your doctor may discuss timing, dose, how long you used the medicine, your medical history, and whether additional monitoring is appropriate.

There is also a pregnancy exposure registry that collects health information about people exposed to Otezla during pregnancy. These registries help researchers learn more about medication safety over time. Participation may help future patients and clinicians make better-informed decisions.

Otezla and Breastfeeding

Breastfeeding brings a different set of questions. The main issue is whether apremilast passes into human milk, how much might reach a nursing infant, and whether it could affect the infant or milk production. At this time, there are no adequate human data showing the presence of apremilast in breast milk, its effects on a breastfed infant, or its effects on milk production.

Animal data show that apremilast was detected in the milk of lactating mice. When a medication is found in animal milk, it is often considered possible that it may be present in human milk too, though the amount can differ. Lactation references generally recommend avoiding apremilast while breastfeeding when possible, especially when nursing a newborn or preterm infant, because the evidence is limited.

This does not mean every breastfeeding parent has the same answer. A clinician may consider disease severity, infant age, whether the baby was born full-term, other treatment options, and the parent’s need for symptom control. The benefits of breastfeeding and the benefits of maternal treatment both matter. The best decision is usually a shared decision, not a one-size-fits-all rule written on a sticky note.

Can Otezla Affect Fertility?

Human data are limited on whether Otezla affects fertility. MotherToBaby notes that it is not known whether apremilast makes it harder to become pregnant, while animal studies have not shown a negative effect on fertility. That is somewhat reassuring, but not the same as having large, well-controlled human fertility studies.

If fertility is already a concern, or if you are preparing for assisted reproductive treatment, discuss Otezla with both your prescribing specialist and reproductive care provider. The conversation should include not only the medication itself but also disease control, stress, other prescriptions, and overall health.

Otezla and Birth Control

Because Otezla is not well studied in pregnancy and animal findings raise concerns, people who can become pregnant should ask their healthcare provider about birth control while using it. The best option depends on your health history, preferences, other medications, and pregnancy timeline.

There is no universal “best” birth control method for every Otezla user. Some people prefer long-acting options. Others prefer pills, patches, rings, barriers, or other methods. The important part is not guessing. A quick conversation with a clinician can help match contraception to your medical situation and reduce the chance of an unplanned medication exposure during pregnancy.

Common Side Effects to Know Before Pregnancy or Breastfeeding Decisions

Even outside pregnancy and lactation, Otezla has side effects that matter. The most common include diarrhea, nausea, headache, tension headache, upper respiratory tract infection, and cold-like symptoms. These effects are often most noticeable during the first few weeks of treatment, which is why Otezla is typically started with a gradual dose titration.

For a person who is pregnant, trying to conceive, or caring for a newborn, side effects can feel more disruptive. Nausea plus pregnancy nausea? That is not exactly a dream team. Diarrhea can raise concerns about hydration, especially if it is severe or persistent. Headaches, appetite changes, and fatigue may overlap with pregnancy or postpartum symptoms, making it harder to know what is causing what.

Otezla can also be associated with weight loss. Weight monitoring is part of safe use, especially in children and in adults who are already underweight or losing weight unintentionally. Mood changes, including worsening depression, are also an important warning. Anyone with a history of depression or significant mood symptoms should discuss this before starting treatment and report changes promptly.

Drug Interactions: The “Tell Your Doctor Everything” Section

Otezla can interact with certain medications and supplements that affect how the body processes it. Strong CYP450 enzyme inducers, such as rifampin, can reduce apremilast exposure and may make Otezla less effective. Some seizure medications and the herbal supplement St. John’s wort are also commonly mentioned in interaction discussions.

This is why your care team needs a complete medication list, including over-the-counter products, vitamins, herbal supplements, and “just something natural” items. Natural does not always mean harmless. Poison ivy is natural too, and nobody invites it to brunch.

Possible Alternatives During Pregnancy or Breastfeeding

For psoriasis, many dermatology resources consider moisturizers and emollients among the lowest-risk supportive measures during pregnancy. They do not cure psoriasis, but they can reduce dryness, friction, and irritation. Low- to mid-strength topical corticosteroids may be used when appropriate, usually with careful attention to strength, amount, location, and duration.

Narrowband UVB phototherapy is often considered an option during pregnancy when topical care is not enough. It does not involve a systemic drug circulating through the body in the same way an oral medication does. However, phototherapy still requires medical supervision, scheduling, and sun-protection guidance.

For psoriatic arthritis, options are more individualized. Some medications have more pregnancy and lactation experience than others, but the choice depends on diagnosis, disease activity, previous response, insurance coverage, and specialist guidance. Rheumatology and dermatology teams often work with obstetric providers to choose the safest effective plan.

How to Talk With Your Doctor About Otezla and Reproductive Health

The best appointment is not the one where you remember every question while sitting in the parking lot afterward. Bring a short list. Tell your doctor whether you are pregnant, trying to conceive, using birth control, breastfeeding, planning to breastfeed, or unsure about timing. Mention any past pregnancy complications, kidney disease, weight changes, mood history, and all medications or supplements.

Ask what would happen if you stopped Otezla, what symptoms might return, how quickly a flare could appear, and what your backup plan would be. If an alternative is recommended, ask how long it usually takes to work and whether it is considered compatible with pregnancy or breastfeeding. Also ask who should be contacted first if symptoms worsen: dermatologist, rheumatologist, obstetrician, primary care doctor, or all of the above.

Practical Scenarios

Scenario 1: You Are Stable on Otezla and Want to Get Pregnant

This is the ideal time to plan. Your clinician may discuss stopping Otezla before trying to conceive or switching to a therapy with more pregnancy data. The timing should be personalized. Do not stop suddenly without a plan, especially if your disease has been difficult to control.

Scenario 2: You Just Found Out You Are Pregnant

Call your healthcare provider promptly. Share when your last dose was, how long you have been taking Otezla, your dose, and the first day of your last menstrual period if you know it. Your provider can help decide next steps and whether registry participation is appropriate.

Scenario 3: You Want to Breastfeed but Need Treatment

Ask about alternatives with more lactation experience. The answer may differ if your baby is premature, newborn, older, or exclusively breastfed. The plan may also depend on whether your disease is mild, moderate, or severe after delivery.

Experiences Related to Otezla, Pregnancy, Breastfeeding, and Real-Life Decision-Making

In real life, medication decisions rarely happen in the neat, tidy way medical articles describe them. People do not wake up inside a textbook chapter labeled “Reproductive Health Considerations.” They wake up with itchy plaques, swollen joints, mouth ulcers, a positive pregnancy test, a baby who needs feeding, or a calendar reminder that says “rheumatology appointment” right when life is already overflowing.

One common experience is emotional whiplash. A person may finally find that Otezla helps control symptoms after months or years of trial and error. Then pregnancy planning begins, and suddenly the medication that felt like a solution becomes a question mark. That can be frustrating. It is normal to feel disappointed if a doctor recommends changing a treatment that has been working. Good disease control is not a small thing; it affects sleep, confidence, movement, work, relationships, and daily comfort.

Another real-world challenge is timing. Some people plan pregnancy carefully, while others discover they are pregnant after taking Otezla for several weeks. The second situation can feel scary, but it is also common with many medications. The most helpful response is organized action: write down the dose, start date, last dose, other medications, and symptoms; then contact the prescribing clinician and pregnancy care provider. This turns panic into a plan.

Breastfeeding decisions can be equally personal. A parent may want to breastfeed but also fear a severe postpartum flare. Psoriasis and inflammatory arthritis may change after delivery, and sleep deprivation can make every symptom feel louder. Some parents decide to use a different treatment while nursing. Others may decide, with medical guidance, that controlling disease is the priority and feeding plans need to be flexible. There is no prize for suffering silently while pretending everything is fine. Healthy parent, healthy baby, and realistic treatment planning all belong in the same conversation.

People also report that side effects matter more during reproductive transitions. Nausea from medication may be tolerable on an ordinary Tuesday, but much harder during early pregnancy. Diarrhea may be manageable at home, but stressful when caring for a newborn or recovering after delivery. Weight loss may be concerning when nutritional needs are higher. Mood changes deserve special attention during pregnancy and postpartum, when emotional health is already important to monitor.

A useful experience-based tip is to create a “medication decision folder.” This can be a digital note, not an actual folder unless you enjoy office supplies. Include your diagnosis, current medications, past treatments, allergies, pregnancy plans, breastfeeding goals, and questions for each specialist. Bring the same information to dermatology, rheumatology, obstetrics, and primary care visits. Repeating yourself is exhausting; having notes makes it easier.

Another helpful habit is asking doctors to explain the “why” behind recommendations. If your clinician says to avoid Otezla during pregnancy or breastfeeding, ask what evidence supports that recommendation and what alternatives fit your condition. If they suggest a switch, ask how the transition will be managed. If they recommend monitoring, ask what symptoms should trigger a call. Clear instructions reduce anxiety and prevent late-night internet spirals, which are rarely known for their calming effect.

Finally, it helps to remember that medication safety knowledge evolves. Pregnancy registries and lactation databases exist because patients and clinicians need better information. The fact that data are limited does not mean you did something wrong by asking questions. It means your questions are exactly the right ones.

Conclusion

Otezla can be an important treatment for plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s disease, but pregnancy and breastfeeding require extra caution. Human pregnancy data are limited, animal studies suggest a potential risk of fetal loss, and breastfeeding data in humans are not available. Because of this uncertainty, people who are pregnant, planning pregnancy, able to become pregnant, or breastfeeding should discuss Otezla with their healthcare provider before starting, stopping, or continuing treatment.

The best plan balances disease control with reproductive safety. That may mean changing medications, using topical treatment, considering phototherapy, adjusting timing, joining a pregnancy registry, or coordinating care among multiple specialists. The smartest move is not to guess. It is to ask early, plan clearly, and keep the conversation open.